Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
Conditions
Interventions
Sponsors
Dr Sharmila Pimple
Eligibility
Inclusion criteria
Inclusion criteria: Lab diagnosed HIV-positive women Female patients aged 25-65 years Non pregnant women
Exclusion criteria
Exclusion criteria: Past history of Cervical Cancer Pregnant Women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Sociodemographic Profile 2. Reproductive & Sexual history 3. High risk HPV prevalence HPVDNA 16, HPV DNA18, Other High-risk types 4. Conventional PAP cytology ASCUS, LSIL, HSIL, AGC, ASC-H, SCC 5. Prevalence of Acetowhite lesions through VIA with Mobile ODT 6. Acceptability of HPV self-sampling and Mobile ODT- - % of eligible women aware of cervical cancer screening. - % of eligible women screened through hrHPV self-testing. - % of eligible women screened through VIA with Mobile ODT. 7. Feasibility of HPV self-sampling and VIA with Mobile ODT: - Self-sample HPV DNA screening coverage - VIA with Mobile ODT screening coverage - Screen positive compliance with Reference diagnosis: Conventional CytologyTimepoint: 24 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Sharmila Pimple
Tata Memorial Hospital
Outcome results
None listed